🇺🇸 FDA
Patent

US 11478425

Extended release compositions comprising pyridostigmine

granted A61KA61K31/4425A61K9/0065

Quick answer

US patent 11478425 (Extended release compositions comprising pyridostigmine) held by Amneal Complex Products Research LLC expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amneal Complex Products Research LLC
Grant date
Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/4425, A61K9/0065, A61K9/1676, A61K9/2009